Five plaintiffs were awarded a total of $502 million dollars in the 2nd test (bellwether) case to go to trial against Johnson & Johnson (J&J) relating to its Depuy Pinnacle hip implants, in January of 2016,  J&J appealed the verdict, which the trial judge reduced to $151 million dollars.  The 5th Circuit Court of Appeals heard oral argument on December 7, 2017, and issued their opinion  in April 2018. The Fifth Circuit overturned the entire verdict and remanded the case back to the Northern District of Texas and Judge Ed Kinkeade for a new trial.… Read More

A jury in Dallas federal court ordered Johnson & Johnson’s DePuy Orthopaedics unit to pay more than $1 billion dollars to six Pinnacle hip recipients who suffered serious medical complications from their DePuy Pinnacle hip implants. The jury found that the metal-on-metal Pinnacle hips were defectively designed, and that J&J and DePuy failed to warn patients and doctors about the risks.… Read More

By Marilyn  T. McGoldrick, Esq. Published on Aug 22, 2014 Boston Scientific won a defense verdict in the first transvaginal mesh (TVM) case to go to trial in Middlesex Superior Court. The jury ruled that plaintiff Diane Albright had not proved that her Pinnacle vaginal mesh device was defectively designed, or that it lacked adequate… Read More

DePuy Orthopaedics, Inc., recalled the DePuy ASR™ XL Acetabular Hip System on August 24, 2010, three years ago this coming Saturday. The three-year statute of limitations applicable to Massachusetts claims (and claims in states with a similar limitations period) could possibly expire in many cases at the end of this month. DePuy Orthopaedics, a division of Johnson & Johnson, recalled its ASR Hip System because of an exceptionally high failure rate and resulting metal poisoning. DePuy’s Pinnacle® metal-on-metal hip system, which remains on the market today but is being phased out by J&J, is experiencing similar failures.… Read More